BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10390508)

  • 1. A micromethod for the in vitro micronucleus assay.
    Nesslany F; Marzin D
    Mutagenesis; 1999 Jul; 14(4):403-10. PubMed ID: 10390508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the in vitro rat hepatocyte micronucleus assay in genetic toxicology testing.
    Müller-Tegethoff K; Kersten B; Kasper P; Müller L
    Mutat Res; 1997 Aug; 392(1-2):125-38. PubMed ID: 9269337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study.
    Lorge E; Thybaud V; Aardema MJ; Oliver J; Wakata A; Lorenzon G; Marzin D
    Mutat Res; 2006 Aug; 607(1):13-36. PubMed ID: 16815079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU).
    Matsushima T; Hayashi M; Matsuoka A; Ishidate M; Miura KF; Shimizu H; Suzuki Y; Morimoto K; Ogura H; Mure K; Koshi K; Sofuni T
    Mutagenesis; 1999 Nov; 14(6):569-80. PubMed ID: 10567032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of genetically engineered V79 Chinese hamster cultures expressing rat liver CYP1A1, 1A2 and 2B1 cDNAs in micronucleus assays.
    Ellard S; Mohammed Y; Dogra S; Wölfel C; Doehmer J; Parry JM
    Mutagenesis; 1991 Nov; 6(6):461-70. PubMed ID: 1800893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of eight known or suspected aneugens by the in vitro human lymphocyte micronucleus test.
    Van Hummelen P; Kirsch-Volders M
    Mutagenesis; 1992 Nov; 7(6):447-55. PubMed ID: 1474920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells.
    Wakata A; Matsuoka A; Yamakage K; Yoshida J; Kubo K; Kobayashi K; Senjyu N; Itoh S; Miyajima H; Hamada S; Nishida S; Araki H; Yamamura E; Matsui A; Thybaud V; Lorenzon G; Marzin D; Lorge E
    Mutat Res; 2006 Aug; 607(1):88-124. PubMed ID: 16782396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the use of primary Chinese hamster liver cultures and genetically engineered immortal V79 Chinese hamster cell lines expressing rat liver CYP1A1, 1A2 and 2B1 cDNAs in micronucleus assays.
    Ellard S; Parry JM
    Toxicology; 1993 Oct; 82(1-3):131-49. PubMed ID: 8236272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens.
    Hashimoto K; Nakajima Y; Matsumura S; Chatani F
    Toxicol In Vitro; 2010 Feb; 24(1):208-16. PubMed ID: 19747535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an in vitro micronucleus assay platform in TK6 cells.
    Sobol Z; Homiski ML; Dickinson DA; Spellman RA; Li D; Scott A; Cheung JR; Coffing SL; Munzner JB; Sanok KE; Gunther WC; Dobo KL; Schuler M
    Mutat Res; 2012 Jul; 746(1):29-34. PubMed ID: 22445949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a high-content screening in vitro micronucleus assay in CHO-k1 and HepG2 cells.
    Westerink WM; Schirris TJ; Horbach GJ; Schoonen WG
    Mutat Res; 2011 Sep; 724(1-2):7-21. PubMed ID: 21658468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents.
    Bryce SM; Bemis JC; Mereness JA; Spellman RA; Moss J; Dickinson D; Schuler MJ; Dertinger SD
    Environ Mol Mutagen; 2014 Aug; 55(7):542-55. PubMed ID: 24756928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells.
    Diaz D; Scott A; Carmichael P; Shi W; Costales C
    Mutat Res; 2007 Jun; 630(1-2):1-13. PubMed ID: 17446119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The automated micronucleus assay for early assessment of genotoxicity in drug discovery.
    Tilmant K; Gerets HH; De Ron P; Cossu-Leguille C; Vasseur P; Dhalluin S; Atienzar FA
    Mutat Res; 2013 Feb; 751(1):1-11. PubMed ID: 23159395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Aneugens and Clastogens in the In Vitro Micronucleus Test by Kinetochore Scoring Using Automated Image Analysis.
    Wilde S; Queisser N; Holz C; Raschke M; Sutter A
    Environ Mol Mutagen; 2019 Apr; 60(3):227-242. PubMed ID: 30561837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test.
    Meintières S; Biola A; Pallardy M; Marzin D
    Environ Mol Mutagen; 2003; 41(1):14-27. PubMed ID: 12552588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on the SFTG international collaborative study on the in vitro micronucleus test: to Cyt-B or not to Cyt-B?
    Fenech M
    Mutat Res; 2006 Aug; 607(1):9-12. PubMed ID: 16720100
    [No Abstract]   [Full Text] [Related]  

  • 18. Micronuclei induced by aneugens and clastogens in mononucleate and binucleate cells using the cytokinesis block assay.
    Rosefort C; Fauth E; Zankl H
    Mutagenesis; 2004 Jul; 19(4):277-84. PubMed ID: 15215326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proposal for a simple way to distinguish aneugens from clastogens in the in vitro micronucleus test.
    Matsuoka A; Matsuura K; Sakamoto H; Hayashi M; Sofuni T
    Mutagenesis; 1999 Jul; 14(4):385-9. PubMed ID: 10390505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM Working Group on the in vitro micronucleus test. Gesellschaft für Umwelt-Mutations-forschung.
    Miller B; Pötter-Locher F; Seelbach A; Stopper H; Utesch D; Madle S
    Mutat Res; 1998 Feb; 410(1):81-116. PubMed ID: 9587425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.